International Journal of Cancer · 2014 · 40 citations · 34 references
Life SciencesInfectious DiseasesPathologyImmunopathologyMolecular VirologyVirologyHiv EpidemiologyImmunodeficiency DisordersKaposi SarcomaOncogenic VirusesViral EpidemiologyAcquired Immunodeficiency SyndromeAntibody TiteringCase-control Study DesignHiv Antibody DetectionHiv Co-infection EpidemiologyKshv LatencyLatency-associated Nuclear AntigenNested Case-control Design
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both the causative agent, Kaposi's sarcoma associated-herpesvirus (KSHV), and the major risk factor, HIV, are prevalent. In a nested case-control study within a long-standing clinical cohort in rural Uganda, we used stored sera to examine the evolution of antibody titres against the KSHV antigens K8.1 and latency-associated nuclear antigen (LANA) among 30 HIV-infected subjects who subsequently developed HIV-related KS (cases) and among 108 matched HIV/KSHV coinfected controls who did not develop KS. Throughout the 6 years prior to diagnosis, antibody titres to K8.1 and LANA were significantly higher among cases than controls (p < 0.0001), and titres increased prior to diagnosis in the cases. K8.1 titres differed more between KS cases and controls, compared to LANA titres. These differences in titre between cases and controls suggest a role for lytic viral replication in the pathogenesis of HIV-related KS in this setting.
34
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Freddie Bray, Jiansong Ren, E. Masuyer et al. · International Journal of Cancer · 2012 · 1.9K citations · Full text
N. Dupin, Cyril Fisher, Paul Kellam et al. · Proceedings of the National Academy of Sciences · 1999 · 705 citations